Sonoscape Medical (SZSE:300633) Debt-to-Equity : 0.09 (As of Mar. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Sonoscape Medical Debt-to-Equity?

Sonoscape Medical's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ¥264 Mil. Sonoscape Medical's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ¥32 Mil. Sonoscape Medical's Total Stockholders Equity for the quarter that ended in Mar. 2024 was ¥3,256 Mil. Sonoscape Medical's debt to equity for the quarter that ended in Mar. 2024 was 0.09.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Sonoscape Medical's Debt-to-Equity or its related term are showing as below:

SZSE:300633' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.01 Med: 0.09 Max: 0.5
Current: 0.09

During the past 12 years, the highest Debt-to-Equity Ratio of Sonoscape Medical was 0.50. The lowest was 0.01. And the median was 0.09.

SZSE:300633's Debt-to-Equity is ranked better than
68.83% of 709 companies
in the Medical Devices & Instruments industry
Industry Median: 0.21 vs SZSE:300633: 0.09

Sonoscape Medical Debt-to-Equity Historical Data

The historical data trend for Sonoscape Medical's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sonoscape Medical Debt-to-Equity Chart

Sonoscape Medical Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-Equity

Get a 7-Day Free Trial

0.33

0.36

0.05

0.08

0.02

Sonoscape Medical Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Debt-to-Equity	Get a 7-Day Free Trial															0.09	0.06	0.05	0.02	0.09

Competitive Comparison of Sonoscape Medical's Debt-to-Equity

For the Medical Devices subindustry, Sonoscape Medical's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sonoscape Medical's Debt-to-Equity Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Sonoscape Medical's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Sonoscape Medical's Debt-to-Equity falls into.

Sonoscape Medical Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Sonoscape Medical's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(38.437	+	34.007)	/	3145.954
	=	0.02

Sonoscape Medical's Debt to Equity Ratio for the quarter that ended in Mar. 2024 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(263.584	+	32.42)	/	3256.348
	=	0.09

Sonoscape Medical (SZSE:300633) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Sonoscape Medical Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Sonoscape Medical's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Sonoscape Medical (SZSE:300633) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sonoscape Medical Corp (SZSE:300633) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

Yuquan Road, 10th Floor,Yizhe Building, Nanshan District, Guangdong Province, Shenzhen, CHN, 518051

Website

http://www.sonoscape.com

Sonoscape Medical Corp is a Chinese manufacturer of medical devices for ultrasound diagnostic systems and transducers. The company's product categories include Ultrasound, Endoscope which also includes video equipment, and Electrocardiography consisting of veterinary ECG and resting ECG. Ultrasound category covers color Doppler trolley systems, color Doppler HCU, B/W trolley systems, and probe, among others. The organization has a business presence in China and in other countries.

Sonoscape Medical (SZSE:300633) Headlines

No Headlines